Emerging technologies of polymeric nanoparticles in cancer drug delivery

Journal of Nanomaterials

Volumn 2011, Issue , 2011, Pages

  Brewer, Erik ^a   Coleman, Jason ^a   Lowman, Anthony ^a  

^a Drexel University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMERS; DELIVERY METHODS; DRUG DELIVERY DEVICES; DRUG RELEASE; EMERGING TECHNOLOGIES; IN-VITRO; INTRACELLULAR DELIVERY; NANO-MATERIALS; NANOMATERIAL; PH-RESPONSIVE; POLYMERIC NANOPARTICLES; RESIDENCE TIME; SIDE EFFECT; SMART TECHNOLOGY;

CHEMOTHERAPY; DRUG DELIVERY; DRUG INTERACTIONS; NANOSTRUCTURED MATERIALS; POLYMERS;

DRUG DOSAGE;

EID: 77957837775     PISSN: 16874110     EISSN: 16874129     Source Type: Journal    
DOI: 10.1155/2011/408675     Document Type: Review

References (142)

1. Working P. K., Dayan A. D., Pharmacological-toxicological Expert Report. Caelyx. (Stealth liposomal doxorubicin HCl) Human and Experimental Toxicology 1996 15 9 751 785
2. ten Hagen T. L., Seynhaeve A. L., van Tiel S. T., Ruiter D. J., Eggermont A. M., Pegylated liposomal tumor necrosis factor- results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal doxorubicin (Doxil) in soft tissue sarcoma-bearing rats International Journal of Cancer 2002 97 1 115 120
3. Gabizon A., Shmeeda H., Barenholz Y., Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies Clinical Pharmacokinetics 2003 42 5 419 436
4. Gabizon A. A., Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes Cancer Research 1992 52 4 891 896
5. Northfelt D. W., Martin F. J., Working P., Volberding P. A., Russell J., Newman M., Amantea M. A., Kaplan L. D., Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma Journal of Clinical Pharmacology 1996 36 1 55 63
6. Allen T. M., Cullis P. R., Drug delivery systems: entering the mainstream Science 2004 303 5665 1818 1822
7. Yokoyama M., Okano T., Sakurai Y., Ekimoto H., Shibazaki C., Kataoka K., Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood Cancer Research 1991 51 12 3229 3236
8. Hans M. L., Lowman A. M., Biodegradable nanoparticles for drug delivery and targeting Current Opinion in Solid State and Materials Science 2002 6 4 319 327
9. Zhang L., Radovic-Moreno A. F., Alexis F., Gu F. X., Basto P. A., Bagalkot V., Jon S., Langer R. S., Farokhzad O. C., Co-delivery of hydrophobic and hydrophilic drugsfrom nanoparticle-aptamer bioconjugates ChemMedChem 2007 2 9 1268 1271
10. Herrero-Vanrell R., Refojo M. F., Biodegradable microspheres for vitreoretinal drug delivery Advanced Drug Delivery Reviews 2001 52 1 5 16
11. Lewis D. H., Chasin M., Langer R., Controlled release of bioactive agents from lactide/glycolide polymers Biodegradable Polymers as Drug Delivery Devices 1990 New York, NY, USA Marcel Dekker 1 41
12. Langer R., Vacanti J. P., Tissue engineering Science 1993 260 5110 920 926
13. Chiellini E., Solaro R., Biodegradable polymeric materials Advanced Materials 1996 8 4 305 313
14. Jeong B., Bae Y. H., Lee D. S., Kim S. W., Biodegradable block copolymers as injectable drug-delivery systems Nature 1997 388 6645 860 862
15. Okada K., Kawaide H., Kuzuyama T., Seto H., Curtis I. S., Kamiya Y., Antisense and chemical suppression of the nonmevalonate pathway affects ent-kaurene biosynthesis in Arabidopsis Planta 2002 215 2 339 344
16. Lavasanifar A., Samuel J., Kwon G. S., Poly(ethylene oxide)-block-poly(L- amino acid) micelles for drug delivery Advanced Drug Delivery Reviews 2002 54 2 169 190
17. Yokoyama M., Miyauchi M., Yamada N., Okano T., Sakurai Y., Kataoka K., Inoue S., Characterization and anticancer activity of the micelle-forming polymeric anticancer drug Adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer Cancer Research 1990 50 6 1693 1700
18. Lasic D. D., Vallner J. J., Working P. K., Sterically stabilized liposomes in cancer therapy and gene delivery Current Opinion in Molecular Therapeutics 1999 1 2 177 185
19. Allen T. M., Newman M. S., Woodle M. C., Mayhew E., Uster P. S., Pharmacokinetics and anti-tumor activity of vincristine encapsulated in sterically stabilized liposomes International Journal of Cancer 1995 62 2 199 204
20. Gref R., Lck M., Quellec P., Marchand M., Dellacherie E., Harnisch S., Blunk T., Mller R. H., Stealth corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption Colloids and Surfaces B 2000 18 3-4 301 313
21. Gref R., Minamitake Y., Peracchia M. T., Trubetskoy V., Torchilin V., Langer R., Biodegradable long-circulating polymeric nanospheres Science 1994 263 5153 1600 1603
22. Tobo M., Gref R., Snchez A., Langer R., Alonso M. J., Stealth PLA-PEG nanoparticles as protein carriers for nasal administration Pharmaceutical Research 1998 15 2 270 275
23. Owens D. E. III, Peppas N. A., Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles International Journal of Pharmaceutics 2006 307 1 93 102
24. Zhang X., Li Y., Chen X., Wang X., Xu X., Liang Q., Hu J., Jing X., Synthesis and characterization of the paclitaxel/MPEG-PLA block copolymer conjugate Biomaterials 2005 26 14 2121 2128 (Pubitemid 39575355)
25. Maeda H., Wu J., Sawa T., Matsumura Y., Hori K., Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review Journal of Controlled Release 2000 65 1-2 271 284
26. Duncan R., Vicent M. J., Greco F., Nicholson R. I., Polymer-drug conjugates: towards a novel approach for the treatment of endrocine-related cancer Endocrine-Related Cancer 2005 12 supplement 1 S189 S199
27. Li L., ten Hagen T. L. M., Schipper D., Wijnberg T. M., van Rhoon G. C., Eggermont A. M.M., Lindner L. H., Koning G. A., Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia Journal of Controlled Release 2010 143 2 274 279
28. Cagnoni P. J., Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients Journal of Antimicrobial Chemotherapy 2002 49 supplement 1 81 86
29. Judson I., Radford J. A., Harris M., Blay J.-Y., Van Hoesel Q., Le Cesne A., Van Oosterom A. T., Clemons M. J., Kamby C., Hermans C., Whittaker J., Donato Di Paola E., Verweij J., Nielsen S., Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group European Journal of Cancer 2001 37 7 870 877
30. Walsh T. J., Finberg R. W., Arndt C., Hiemenz J., Schwartz C., Bodensteiner D., Pappas P., Seibel N., Greenberg R. N., Dummer S., Schuster M., Holcenberg J. S., Dismukes W. E., Liposomal amphotericin b for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group New England Journal of Medicine 1999 340 10 764 771
31. Lu J. Y., Lowe D. A., Kennedy M. D., Low P. S., Folate-targeted enzyme prodrug cancer therapy utilizing penicillin-V amidase and a doxorubicin prodrug Journal of Drug Targeting 1999 7 1 43 53
32. Lu Y., Low P. S., Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors Cancer Immunology, Immunotherapy 2002 51 3 153 162
33. Yoo H. S., Park T. G., Folate receptor targeted biodegradable polymeric doxorubicin micelles Journal of Controlled Release 2004 96 2 273 283
34. Cummings J., McArdle C. S., Studies on the in vivo disposition of adriamycin in human tumours which exhibit different responses to the drug British Journal of Cancer 1986 53 6 835 838
35. Goren D., Horowitz A. T., Tzemach D., Tarshish M., Zalipsky S., Gabizon A., Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump Clinical Cancer Research 2000 6 5 1949 1957
36. Weitman S. D., Weinberg A. G., Coney L. R., Zurawski V. R., Jennings D. S., Kamen B. A., Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis Cancer Research 1992 52 23 6708 6711
37. Reddy J. A., Low P. S., Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation Journal of Controlled Release 2000 64 13 27 37
38. Wang S., Lee R. J., Cauchon G., Gorenstein D. G., Low P. S., Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol Proceedings of the National Academy of Sciences of the United States of America 1995 92 8 3318 3322
39. Yoo H. S., Oh J. E., Lee K. H., Park T. G., Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release Pharmaceutical Research 1999 16 7 1114 1118
40. Yoo H. S., Park T. G., Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer Journal of Controlled Release 2001 70 1-2 63 70
41. Kwon G. S., Kataoka K., Block copolymer micelles as long-circulating drug vehicles Advanced Drug Delivery Reviews 1995 16 2-3 295 309
42. Kwon G., Naito M., Yokoyama M., Okano T., Sakurai Y., Kataoka K., Block copolymer micelles for drug delivery: loading and release of doxorubicin Journal of Controlled Release 1997 48 2-3 195 201
43. Kwon G., Suwa S., Yokoyama M., Okano T., Sakurai Y., Kataoka K., Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-adriamycin conjugates Journal of Controlled Release 1994 29 1-2 17 23
44. Kwon G. S., Yokoyama M., Okano T., Sakurai Y., Kataoka K., Biodistribution of micelle-forming polymer-drug conjugates Pharmaceutical Research 1993 10 7 970 974
45. Li Y.-P., Pei Y.-Y., Zhang X.-Y., Gu Z.-H., Zhou Z.-H., Yuan W.-F., Zhou J.-J., Zhu J.-H., Gao X.-J., PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats Journal of Controlled Release 2001 71 2 203 211
46. Joyce G. F., Amplification, mutation and selection of catalytic RNA Gene 1989 82 1 83 87
47. Jayasena S. D., Aptamers: an emerging class of molecules that rival antibodies in diagnostics Clinical Chemistry 1999 45 9 1628 1650
48. Tombelli S., Minunni M., Luzi E., Mascini M., Aptamer-based biosensors for the detection of HIV-1 Tat protein Bioelectrochemistry 2005 67 2 135 141
49. Mairal T., zalp V. C., Lozano Snchez P., Mir M., Katakis I., O'Sullivan C. K., Aptamers: molecular tools for analytical applications Analytical and Bioanalytical Chemistry 2008 390 4 989 1007
50. Nutiu R., Li Y., Structure-switching signaling aptamers: transducing molecular recognition into fluorescence signaling Chemistry 2004 10 8 1868 1876
51. Hoffman P. C., Mauer A. M., Vokes E. E., Lung cancer Lancet 2000 355 9202 479 485
52. Mulshine J. L., Sullivan D. C., Lung cancer screening New England Journal of Medicine 2005 352 26 2714 2720
53. Smith J. E., Medley C. D., Tang Z., Shangguan D., Lofton C., Tan W., Aptamer-conjugated nanoparticles for the collection and detection of multiple cancer cells Analytical Chemistry 2007 79 8 3075 3082
54. Zhao X., Hilliard L. R., Mechery S. J., Wang Y., Bagwe R. P., Jin S., Tan W., A rapid bioassay for single bacterial cell quantitation using bioconjugated nanoparticles Proceedings of the National Academy of Sciences of the United States of America 2004 101 42 15027 15032
55. Zhao X., Tapec-Dytioco R., Tan W., Ultrasensitive DNA detection using highly fluorescent bioconjugated nanoparticles Journal of the American Chemical Society 2003 125 38 11474 11475
56. Zhao X., Bagwe R. P., Tan W., Development of organic-dye-doped silica nanoparticles in a reverse microemulsion Advanced Materials 2004 16 2 173 176
57. Herr J. K., Smith J. E., Medley C. D., Shangguan D., Tan W., Aptamer-conjugated nanoparticles for selective collection and detection of cancer cells Analytical Chemistry 2006 78 9 2918 2924
58. Chen H. W., Medley C. D., Sefah K., Shangguan D., Tang Z., Meng L., Smith J. E., Tan W., Molecular recognition of small-cell lung cancer cells using aptamers ChemMedChem 2008 3 6 991 1001
59. Javier D. J., Nitin N., Levy M., Ellington A., Richards-Kortum R., Aptamer-targeted gold nanoparticles as molecular-specific contrast agents for reflectance imaging Bioconjugate Chemistry 2008 19 6 1309 1312
60. Huang C.-C., Chiu S.-H., Huang Y.-F., Chang H.-T., Aptamer-functionalized gold nanoparticles for turn-on light switch detection of platelet-derived growth factor Analytical Chemistry 2007 79 13 4798 4804
61. Farokhzad O. C., Cheng J., Teply B. A., Sherifi I., Jon S., Kantoff P. W., Richie J. P., Langer R., Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo Proceedings of the National Academy of Sciences of the United States of America 2006 103 16 6315 6320
62. Farokhzad O. C., Jon S., Khademhosseini A., Tran T.-N. T., LaVan D. A., Langer R., Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells Cancer Research 2004 64 21 7668 7672
63. Farokhzad O. C., Khademhosseini A., Jon S., Hermmann A., Cheng J., Chin C., Kiselyuk A., Teply B., Eng G., Langer R., Microfluidic system for studying the interaction of nanoparticles and microparticles with cells Analytical Chemistry 2005 77 17 5453 5459
64. Dhar S., Gu F. X., Langer R., Farokhza O. C., Lippard S. J., Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGAPEG nanoparticles Proceedings of the National Academy of Sciences of the United States of America 2008 105 45 17356 17361
65. Wu Y., Sefah K., Liu H., Wang R., Tan W., DNA aptamer-micelle as an efficient detection/delivery vehicle toward cancer cells Proceedings of the National Academy of Sciences of the United States of America 2010 107 1 5 10
66. Walsh C., Molecular mechanisms that confer antibacterial drug resistance Nature 2000 406 6797 775 781
67. Hanahan D., Bergers G., Bergsland E., Less is, more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice Journal of Clinical Investigation 2000 105 8 1045 1047
68. Joensuu H., Holli K., Heikkinen M., Suonio E., Aro A. R., Hietanen P., Huovinen R., Combination chemotherapy versus single-agent therapy as first- and second-line treatment in metastatic breast cancer: a prospective randomized trial Journal of Clinical Oncology 1998 16 12 3720 3730
69. Wang Y., Gao S., Ye W.-H., Yoon H. S., Yang Y.-Y., Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer Nature Materials 2006 5 10 791 796
70. Wang Y., Wang L.-S., Goh S.-H., Yang Y.-Y., Synthesis and characterizationo of cationic micelles self-assembled from a biodegradable copolymer for gene delivery Biomacromolecules 2007 8 3 1028 1037
71. Wiradharma N., Tong Y. W., Yang Y.-Y., Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect Biomaterials 2009 30 17 3100 3109
72. Cerchia L., Giangrande P. H., McNamara J. O., de Franciscis V., Cell-specific aptamers for targeted therapies Methods in Molecular Biology 2009 535 59 78
73. Chu T. C., Twu K. Y., Ellington A. D., Levy M., Aptamer mediated siRNA delivery Nucleic Acids Research 2006 34 10, article e73
74. McNamara J. O. II, Andrechek E. R., Wang Y., Viles K. D., Rempel R. E., Gilboa E., Sullenger B. A., Giangrande P. H., Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras Nature Biotechnology 2006 24 8 1005 1015
75. Kim E., Jung Y., Choi H., Yang J., Suh J.-S., Huh Y.-M., Kim K., Haam S., Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex Biomaterials 2010 31 16 4592 4599
76. Bae Y., Fukushima S., Harada A., Kataoka K., Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change Angewandte Chemie. International Edition 2003 42 38 4640 4643
77. Helmlinger G., Sckell A., Dellian M., Forbes N. S., Jain R. K., Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism Clinical Cancer Research 2002 8 4 1284 1291
78. Matsumura Y., Maeda H., A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Research 1986 46 12, part 1 6387 6392
79. Kataoka K., Kwon G. S., Yokoyama M., Okano T., Sakurai Y., Block copolymer micelles as vehicles for drug delivery Journal of Controlled Release 1993 24 13 119 132
80. Kwon G. S., Okano T., Polymeric micelles as new drug carriers Advanced Drug Delivery Reviews 1996 21 2 107 116
81. Kwon G. S., Naito M., Yokoyama M., Okano T., Sakurai Y., Kataoka K., Physical entrapment of adriamycin in AB block copolymer micelles Pharmaceutical Research 1995 12 2 192 195
82. Yoo H. S., Lee E. A., Park T. G., Doxorubicin-conjugated biodegradable polymeric micelles having acid-cleavable linkages Journal of Controlled Release 2002 82 1 17 27
83. Yoo H. S., Lee K. H., Oh J. E., Park T. G., In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates Journal of Controlled Release 2000 68 3 419 431
84. Allen T. M., Liposomal drug formulations: rationale for development and what we can expect for the future Drugs 1998 56 5 747 756
85. Momekova D., Rangelov S., Yanev S., Nikolova E., Konstantinov S., Romberg B., Storm G., Lambov N., Long-circulating, pH-sensitive liposomes sterically stabilized by copolymers bearing short blocks of lipid-mimetic units European Journal of Pharmaceutical Sciences 2007 32 4-5 308 317
86. Woodle M. C., Sterically stabilized liposome therapeutics Advanced Drug Delivery Reviews 1995 16 2-3 249 265
87. Zalipsky S., Chemistry of polyethylene glycol conjugates with biologically Advanced Drug Delivery Reviews 1995 16 2-3 157 182
88. Gabizon A., Papahadjopoulos D., Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors Proceedings of the National Academy of Sciences of the United States of America 1988 85 18 6949 6953
89. Hrub M., Kok C., Ulbrich K., Polymeric micellar pH-sensitive drug delivery system for doxorubicin Journal of Controlled Release 2005 103 1 137 148
90. Hong M.-S., Lim S.-J., Oh Y.-K., Kim C.-K., pH-sensitive, serum-stable and long-circulating liposomes as a new drug delivery system Journal of Pharmacy and Pharmacology 2002 54 1 51 58
91. Simes S., Moreira J. N., Fonseca C., Dzgne N., de Lima M. C. P., On the formulation of pH-sensitive liposomes with long circulation times Advanced Drug Delivery Reviews 2004 56 7 947 965
92. Bae Y., Jang W.-D., Nishiyama N., Fukushima S., Kataoka K., Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery Molecular BioSystems 2005 1 3 242 250
93. Bae Y., Kataoka K., Significant enhancement of antitumor activity and bioavailability of intracellular pH-sensitive polymeric micelles by folate conjugation Journal of Controlled Release 2006 116 2 e49 e50
94. Bae Y., Nishiyama N., Fukushima S., Koyama H., Yasuhiro M., Kataoka K., Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy Bioconjugate Chemistry 2005 16 1 122 130
95. Bae Y., Nishiyama N., Kataoka K., In vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments Bioconjugate Chemistry 2007 18 4 1131 1139
96. Shi G., Guo W., Stephenson S. M., Lee R. J., Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations Journal of Controlled Release 2002 80 13 309 319
97. Sudimack J. J., Guo W., Tjarks W., Lee R. J., A novel pH-sensitive liposome formulation containing oleyl alcohol Biochimica et Biophysica Acta 2002 1564 1 31 37
98. Ishida T., Kirchmeier M. J., Moase E. H., Zalipsky S., Allen T. M., Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells Biochimica et Biophysica Acta 2001 1515 2 144 158
99. Li Y., Kwon G. S., Methotrexate esters of poly(ethylene oxide)-block-poly(2-hydroxyethyl-L- aspartamide). Part I: effects of the level of methotrexate conjugation on the stability of micelles and on drug release Pharmaceutical Research 2000 17 5 607 611
100. Rimoli M. G., Avallone L., de Caprariis P., Galeone A., Forni F., Vandelli M. A., Synthesis and characterisation of poly(D,L-lactic acid)-idoxuridine conjugate Journal of Controlled Release 1999 58 1 61 68
101. Zacchigna M., Di Luca G., Cateni F., Zorzet S., Maurich V., Improvement of physicochemical and biopharmaceutical properties of theophylline by poly(ethylene glycol) conjugates Farmaco 2003 58 12 1307 1312
102. Hoste K., de Winne K., Schacht E., Polymeric prodrugs International Journal of Pharmaceutics 2004 277 1-2 119 131
103. Mastrobattista E., Koning G. A., van Bloois L., Filipe A. C. S., Jiskoot W., Storm G., Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteins Journal of Biological Chemistry 2002 277 30 27135 27143
104. Provoda C. J., Stier E. M., Lee K.-D., Tumor cell killing enabled by listeriolysin O-liposome-mediated delivery of the protein toxin gelonin Journal of Biological Chemistry 2003 278 37 35102 35108
105. Ishiguro R., Matsumoto M., Takahashi S., Interaction of fusogenic synthetic peptide with phospholipid bilayers: orientation of the peptide -helix and binding isotherm Biochemistry 1996 35 15 4976 4983
106. Nir S., Nicol F., Szoka F. C. Jr., Surface aggregation and membrane penetration by peptides: relation to pore formation and fusion Molecular Membrane Biology 1999 16 1 95 101
107. Leroux J.-C., Roux E., Le Garrec D., Hong K., Drummond D. C., N-isopropylacrylamide copolymers for the preparation of pH-sensitive liposomes and polymeric micelles Journal of Controlled Release 2001 72 13 71 84
108. Mizoue T., Horibe T., Maruyama K., Takizawa T., Iwatsuru M., Kono K., Yanagie H., Moriyasu F., Targetability and intracellular delivery of anti-BCG antibody-modified, pH-sensitive fusogenic immunoliposomes to tumor cells International Journal of Pharmaceutics 2002 237 1-2 129 137
109. Torchilin V. P., Zhou F., Huang L., pH-Sensitive liposomes Journal of Liposome Research 1993 3 2 201 255
110. Lasic D. D., Novel applications of liposomes Trends in Biotechnology 1998 16 7 307 321
111. Chu C.-J., Dijkstra J., Lai M.-Z., Hong K., Szoka F. C., Efficiency of cytoplasmic delivery by pH-sensitive liposomes to cells in culture Pharmaceutical Research 1990 7 8 824 834
112. Slepushkin V. A., Simes S., Dazin P., Newman M. S., Guo L. S., De Lima M. C. P., Dzgne N., Sterically stabilized pH-sensitive liposomes. Intracellular delivery of aqueous contents and prolonged circulation in vivo Journal of Biological Chemistry 1997 272 4 2382 2388
113. Yatvin M. B., Weinstein J. N., Dennis W. H., Blumenthal R., Design of liposomes for enhanced local release of drugs by hyperthermia Science 1978 202 4374 1290 1293
114. van der Zee J., Gonzlez Gonzlez D., Van Rhoon G. C., Van Dijk J. D. P., Van Putten W. L. J., Hart A. A. M., Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial Lancet 2000 355 9210 1119 1125
115. Issels R. D., Lindner L. H., Wust P., Regional hyperthermia (RHT) improves response and survival when combined with systemic chemotherapy in the management of locally advanced, high grade soft tissue sarcomas (STS) of the extremities, the body wall and the abdomen: a phase III randomised prospective trial (EORTC-ESHO intergroup trial) Proceedings of the 43rd Annual Meeting of ASCO 2007 Chicago, Ill, USA
116. Crile G. Jr., Selective destruction of cancers after exposure to heat Annals of surgery 1962 156 404 407
117. Kong G., Braun R. D., Dewhirst M. W., Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature Cancer Research 2001 61 7 3027 3032
118. Gaber M. H., Wu N. Z., Hong K., Huang S. K., Dewhirst M. W., Papahadjopoulos D., Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks International Journal of Radiation Oncology Biology Physics 1996 36 5 1177 1187
119. Kong G., Braun R. D., Dewhirst M. W., Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size Cancer Research 2000 60 16 4440 4445
120. Huang L., Ozato K., Pagano R. E., Interactions of phospholipid vesicles with murine lymphocytes. I. Vesicle-cell adsorption and fusion as alternate pathways of uptake Membrane Biochemistry 1978 1 1-2 1 25
121. Fajardo L. F., Prionas S. D., Endothelial cells and hyperthermia International Journal of Hyperthermia 1994 10 3 347 353
122. Papahadjopoulos D., Jacobson K., Nir S., Isac T., Phase transitions in phospholipid vesicles. Fluorescence polarization and permeability measurements concerning the effect of temperature and cholesterol Biochimica et Biophysica Acta 1973 311 3 330 348
123. Tsong T. Y., Kinetics of the crystalline liquid crystalline phase transition of dimyristoyl L lecithin bilayers Proceedings of the National Academy of Sciences of the United States of America 1974 71 7 2684 2688
124. Allen T. M., Hansen C., Martin F., Redemann C., Yau-Young A. F., Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo Biochimica et Biophysica Acta 1991 1066 1 29 36
125. Yoshioka H., Surface modification of haemoglobin-containing liposomes with polyethylene glycol prevents liposome aggregation in blood plasma Biomaterials 1991 12 9 861 864
126. Nicholas A. R., Scott M. J., Kennedy N. I., Jones M. N., Effect of grafted polyethylene glycol (PEG) on the size, encapsulation efficiency and permeability of vesicles Biochimica et Biophysica Acta 2000 1463 1 167 178
127. Kenworthy A. K., Hristova K., Needham D., McIntosh T. J., Range and magnitude of the steric pressure between bilayers containing phospholipids with covalently attached poly(ethylene glycol) Biophysical Journal 1995 68 5 1921 1936
128. Mabrey S., Sturtevant J. M., Investigation of phase transitions of lipids and lipid mixtures by high sensitivity differential scanning calorimetry Proceedings of the National Academy of Sciences of the United States of America 1976 73 11 3862 3866
129. Hossann M., Wiggenhorn M., Schwerdt A., Wachholz K., Teichert N., Eibl H., Issels R. D., Lindner L. H., In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomes Biochimica et Biophysica Acta 2007 1768 10 2491 2499
130. Li L., ten Hagen T. L. M., Schipper D., Wijnberg T. M., van Rhoon G. C., Eggermont A. M.M., Lindner L. H., Koning G. A., Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia Journal of Controlled Release 2010 143 2 274 279
131. Needham D., Anyarambhatla G., Kong G., Dewhirst M. W., A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model Cancer Research 2000 60 5 1197 1201
132. Lindner L. H., Eichhorn M. E., Eibl H., Teichert N., Schmitt-Sody M., Issels R. D., Dellian M., Novel temperature-sensitive liposomes with prolonged circulation time Clinical Cancer Research 2004 10 6 2168 2178
133. Kong G., Anyarambhatla G., Petros W. P., Braun R. D., Colvin O. M., Needham D., Dewhirst M. W., Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release Cancer Research 2000 60 24 6950 6957
134. Hauck M. L., La Rue S. M., Petros W. P., Poulson J. M., Yu D., Spasojevic I., Pruitt A. F., Klein A., Case B., Thrall D. E., Needham D., Dewhirst M. W., Phase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors Clinical Cancer Research 2006 12 13 4004 4010
135. Soga O., van Nostrum C. F., Ramzi A., Visser T., Soulimani F., Frederik P. M., Bomans P. H. H., Hennink W. E., Physicochemical characterization of degradable thermosensitive polymeric micelles Langmuir 2004 20 21 9388 9395
136. Neradovic D., van Nostrum C. F., Hennink W. E., Thermoresponsive polymeric micelles with controlled instability based on hydrolytically sensitive N-isopropylacrylamide copolymers Macromolecules 2001 34 22 7589 7591
137. Soga O., van Nostrum C. F., Hennink W. E., Poly(N-(2-hydroxypropyl) methacrylamide mono/di lactate): a new class of biodegradable polymers with tuneable thermosensitivity Biomacromolecules 2004 5 3 818 821
138. Rijcken C. J. F., Veldhuis T. F. J., Ramzi A., Meeldijk J. D., van Nostrum C., Hennink W. E., Novel fast degradable thermosensitive polymeric micelles based on PEG-block-poly(N-(2-hydroxyethyl)methacrylamide-oligolactates) Biomacromolecules 2005 6 4 2343 2351
139. Molineux G., Pegylation: engineering improved pharmaceuticals for enhanced therapy Cancer Treatment Reviews 2002 28 supplement A 13 16
140. Soga O., van Nostrum C. F., Fens M., Rijcken C. J. F., Schiffelers R. M., Storm G., Hennink W. E., Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery Journal of Controlled Release 2005 103 2 341 353
141. Soga O., In vivo efficacy of paclitaxel-loaded thermosensitive biodegradable polymeric micelles, M.S. thesis 2006 Utrecht, The Netherlands Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences
142. Rijcken C. J., Snel C. J., Schiffelers R. M., van Nostrum C. F., Hennink W. E., Hydrolysable core-crosslinked thermosensitive polymeric micelles: synthesis, characterisation and in vivo studies Biomaterials 2007 28 36 5581 5593